Skip to content

Rabies Immune Globulin

Published: July 26, 2026Updated: July 26, 2026

Kedrab is a brand-name medication belonging to the immune globulin class, used for passive immunization against rabies virus. It is administered as part of post-exposure prophylaxis (PEP) in individuals who have been exposed to rabies through bites, scratches, or other contact with rabid animals. This medication provides immediate rabies virus-neutralizing antibodies while the patient develops their own active immune response through vaccination.

Quick summary

Kedrab is a brand-name immune globulin used for rabies post-exposure prophylaxis to provide immediate passive immunity against the rabies virus.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

RxNorm
1992532
Generic
Kedrab
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Post-exposure prophylaxis (PEP) for rabies virus exposure, including bites, scratches, or mucous membrane contact with saliva from confirmed or suspected rabid animals. Used in conjunction with rabies vaccine for comprehensive protection.

Contains rabies virus-neutralizing antibodies that provide immediate passive immunization by binding to and neutralizing the rabies virus at the exposure site and systemically, bridging the gap until active immunity from vaccination develops (typically 7-14 days).

Should be administered as soon as possible after exposure, ideally within the wound or at the site of contact. Dose and administration should follow WHO and local public health guidelines. Not a substitute for rabies vaccination, which is required for long-term immunity. Patients should be monitored for hypersensitivity reactions. Availability and specific formulations may vary by country.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy